In the last cohort of CML patients in different phases of the disease (n = 107, GSE4170), Clu-CD34 and Clu-MPO gene expression signatures were highly associated with blast crisis phase (P < 0.05; Supplementary Figure 2G, 2H). The gene discussed is MPO; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.